NCT07328035 Remission in Adults With Severe Asthma in Thailand
| NCT ID | NCT07328035 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Thammasat University |
| Condition | Severe Asthma |
| Study Type | OBSERVATIONAL |
| Enrollment | 230 participants |
| Start Date | 2026-01-01 |
| Primary Completion | 2026-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 230 participants in total. It began in 2026-01-01 with a primary completion date of 2026-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to determine the prevalence of remission among adults with severe asthma, as well as the factors associated with remission in Thailand. The main question the study aims to answer is: What is the prevalence of remission among adults with severe asthma in Thailand? Participants will complete questionnaires on asthma symptoms and undergo pulmonary function testing and a blood test once.
Eligibility Criteria
Inclusion Criteria: * severe asthma * age 18 years or older Exclusion Criteria: * inability to perform spirometry or fractional exhaled nitric oxide (FeNO) test
Contact & Investigator
Narongkorn Saiphoklang
PRINCIPAL INVESTIGATOR
Thammasat University Faculty of Medicine
Frequently Asked Questions
Who can join the NCT07328035 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Severe Asthma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07328035 currently recruiting?
Yes, NCT07328035 is actively recruiting participants. Contact the research team at M_narongkorn@hotmail.com for enrollment information.
Where is the NCT07328035 trial being conducted?
This trial is being conducted at Pathum Thani, Thailand.
Who is sponsoring the NCT07328035 clinical trial?
NCT07328035 is sponsored by Thammasat University. The principal investigator is Narongkorn Saiphoklang at Thammasat University Faculty of Medicine. The trial plans to enroll 230 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.